Glenmark Pharmaceuticals (BOM:532296) Short-Term Debt : ₹9,906 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Short-Term Debt?

Glenmark Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2024 was ₹9,906 Mil.

Glenmark Pharmaceuticals's quarterly Short-Term Debt declined from Sep. 2023 (₹10,441 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹9,906 Mil).

Glenmark Pharmaceuticals's annual Short-Term Debt declined from Mar. 2022 (₹10,986 Mil) to Mar. 2023 (₹4,956 Mil) but then increased from Mar. 2023 (₹4,956 Mil) to Mar. 2024 (₹9,906 Mil).

Glenmark Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Glenmark Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Short-Term Debt Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

8,256.40

7,986.12

10,986.05

4,955.82

9,905.96

Glenmark Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															4,955.82	-	10,441.36	-	9,905.96

Glenmark Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Glenmark Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Pharmaceuticals (BOM:532296) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Short-Term Debt

Traded in Other Exchanges

GLENMARK:India

Address

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (BOM:532296) Headlines

No Headlines